Cost-effectiveness of frequent in-center hemodialysis

Journal of the American Society of Nephrology

Volumn 19, Issue 9, 2008, Pages 1792-1797

  Lee, Chris P ^a   Zenios, Stefanos A ^b   Chertow, Glenn M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEMODIALYSIS; HOSPITALIZATION; KIDNEY FAILURE; LONGEVITY; MONTE CARLO METHOD; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT DURATION; CHRONIC KIDNEY FAILURE; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MORTALITY; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; UTILIZATION REVIEW;

COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, ECONOMIC; MONTE CARLO METHOD; RENAL DIALYSIS;

EID: 54749125898     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008010001     Document Type: Article

References (22)

1. Teschan PE, Ginn HE, Walker PJ, Bourne JR, Ward JW, Fristoe MW, McLain LW: Assessing adequacy of dialysis using measures of neurological function. Proc Clin Dial Transplant Forum 4: 160-165, 1974
2. US Renal Data System: USRDS 2005 Annual Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005
3. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM: Quality-of-life evaluation using Short Form 36: Comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 35: 293-300, 2000
4. Gorodetskaya I, Zenios SA, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM: Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68: 2801-2808, 2005
5. Heidenheim AP, Muirhead N, Moist L, Lindsay RM: Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 42: 36-41, 2003
6. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S: Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 42: 1020-1035, 2003
7. Traeget J, Galland R, Delawari E, Arkouche W, Hadden R: Six years' experience with short daily hemodialysis: Do the early improvements persist in the mid and long term? Hemodial Int 8: 151-158, 2004
8. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002
9. Ayus JC, Mizani MR, Achinger SG, Thadhani RT, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 16: 2778-2788, 2005
10. Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344: 102-107, 2001
11. Walsh M, Culleton B, Tonelli M, Manns B: A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67: 1500-1508, 2005
12. Suri RS, Nesrallah GR, Mainra R, Garg AX, Lindsay RM, Greene T, Daugirdas J Daily hemodialysis: A systematic review. Clin J Am Soc Nephrol 1: 33-42, 2006
13. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH: Mortality and duration of hemodialysis treatment. JAMA 265: 871-875, 1991
14. Eknoyan G, Beck GJ, Cheung AK, Daugirda JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyere JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group; Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
15. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
16. Saran R, Bragg-Greshem JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
17. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995
18. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations in left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 12: 2759-2767, 2001
19. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
20. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67: 1179-1187, 2005
21. Culleton BF, Walsh M, Klarenbach SW, Scott-Douglas N, Quinn RR, Tonelli M, Donnely S, Freidrich MG, Kumar A, Mahallati H, Hemmelgarn B, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 298: 1291-1299, 2007
22. Lee CP, Zenios SA, Chertow GM: A simulation model to estimate the cost and effectiveness of alternative dialysis strategies. Med Decis Making 26: 535-549, 2006